景峯醫藥(000908.SZ)子公司獲得大連市“專利技術產業化試點企業”榮譽稱號
格隆匯11月20日丨景峯醫藥(000908.SZ)公佈,公司子公司大連華立金港藥業有限公司(“大連金港”)近日獲得由大連市知識產權局頒發的大連市“2018年度專利技術產業化試點企業”榮譽稱號。
根據《大連市專利專項資金管理辦法》(大知發【2018】1號)有關規定,經專家評審或財務審核,大連市知識產權局對專利技術產業化試點企業等項目進行公示後確定,大連金港獲得大連市“2018年度專利技術產業化試點企業”之榮譽稱號。
專利技術產業化是企業自主知識產權向現實生產力轉化的重要表現。大連金港堅持以創新求發展,專注科研、追求品質、精益求精。截止2018年底,大連金港已實現15項專利技術的產業化。
此次大連金港獲得大連市“專利技術產業化試點企業”榮譽稱號,是對公司在技術創新能力、知識產權應用能力以及商業競爭力等各方面的認可,也是公司進一步強化和提升專利創造、運用、保護和管理水平的新起點。大連金港本次獲得上述榮譽稱號不會對公司2019年度經營業績產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.